Evidence map›Paper›PMID 27510325›Full record

ArticleMolecular medicine reports2016

Lycopene inhibits the cell proliferation and invasion of human head and neck squamous cell carcinoma.

Min Ye, Qundan Wu, Min Zhang, Jinbei Huang

Open access · hybridAbstract read
In one paragraph

Article in Molecular medicine reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Molecular pathways modulated by phytochemicals in head and neck cancer.Journal of cell communication and signaling · 2023
    Review
  5. Stem Extract fromMolecules (Basel, Switzerland) · 2022
    Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. A Review of Promising Natural Chemopreventive Agents for Head and Neck Cancer.Cancer prevention research (Philadelphia, Pa.) · 2018
    Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Min YeDepartment of Biopharmacy, School of Pharmacy, Fujian Medical University, Fuzhou, Fujian 350004, P.R. China.
Qundan WuDepartment of Biopharmacy, School of Pharmacy, Fujian Medical University, Fuzhou, Fujian 350004, P.R. China.
Min ZhangDepartment of Biopharmacy, School of Pharmacy, Fujian Medical University, Fuzhou, Fujian 350004, P.R. China.
Jinbei HuangDepartment of Urology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian 350004, P.R. China.
Fujian Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lycopene has been shown to be associated with anticancer effects in numerous tumor types. However, the underlying mechanisms of lycopene in human head and neck squamous cell carcinoma (HNSCC) remain to be determined. The present study aimed to investigate the involvement of lycopene overload and the cytotoxic effects of lycopene on HNSCC cells, and to determine the possible mechanisms involved. Treatment with lycopene at a dose of >10 µM for >24 h inhibited the growth of FaDu and Cal27 cells in a time‑ and dose‑dependent manner. The clearest increase in growth inhibition was due to the apoptotic population being significantly increased. The invasion abilities decreased with 25 µM lycopene exerting significant inhibitory effects (P<0.01). Mechanistic studies revealed that lycopene induced the upregulation of the pro‑apoptotic protein, B‑cell lymphoma‑associated X protein, and therefore, resulted in the inhibition of the protein kinase B and mitogen‑activated protein kinase signaling pathway. These data provided insights into the antitumor activity of lycopene in HNSCC cells.

Indexed as

Anticarcinogenic AgentsApoptosisCarcinoma, Squamous CellCarotenoidsCell Line, TumorCell ProliferationHead and Neck NeoplasmsHumansLycopeneNeoplasm InvasivenessAnticarcinogenic AgentsCarotenoidsLycopene

Identifiers

PMID27510325
PMCPMC5042756
OpenAlexW2515194247

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.